Rothenberg Mace
SEC CIK 1873988 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | Dir | 41.5K | $74.0K | — | 5 | 2023-06-06 | 2026-06-05 |
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 17:55 | 2026-06-05 | TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Dir | A - Grant | $0.00 | +4,000 | 41.5K | +11% | $0 |
| D | 2025-06-09 | 2025-06-05 | TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Dir | A - Grant | $0.00 | +6,250 | 37.5K | +20% | $0 |
| M | 2024-11-18 | 2024-11-14+ | TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Dir | P - Purchase | $3.70 | +20.0K | 21.2K | +1,600% | +$74.0K |
| D | 2024-06-07 | 2024-06-05 | TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Dir | A - Grant | $0.00 | +6,250 | 11.2K | +125% | $0 |
| D | 2023-06-08 | 2023-06-06 | TNGX | Tango Therapeutics, Inc. | Rothenberg Mace | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations